Friday, 7 April 2017

Penfluridol

"penfluridol treatment inhibited the growth of U87MG tumors by 65% and 72% in subcutaneous and intracranial in vivo glioblastoma tumor models respectively"

 Click here for the full study in Oncotarget
Posted by at
Labels:

1 comment:

  1. Stephen W18 May 2017 at 07:41

    Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth

    http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=17425

    ReplyDelete

Subscribe to: Post Comments (Atom)